Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?

Jin Won Huh1, Dong Soon Kim, Yeon-Mok Oh

  • 1Division of Pulmonary and Critical Care Medicine, Asan Medical Center, College of Medicine, University of Ulsan, 388-1, Poongnap-dong, Songpa-gu, Seoul, Korea.

Chest
|December 12, 2007
PubMed
Abstract

Insights

Matrix metalloproteinase-7 (MMP-7) plays a role in idiopathic pulmonary fibrosis (IPF) and cryptogenic organizing pneumonia (COP). MMP-7 levels were similar in both conditions, suggesting it may not determine prognosis in idiopathic interstitial pneumonias.

Area of Science:

  • Pulmonary Medicine
  • Biochemistry
  • Cell Biology

Background:

  • Matrix metalloproteinase-7 (MMP-7) is implicated in idiopathic pulmonary fibrosis (IPF) pathogenesis.
  • Its role in other idiopathic interstitial pneumonias (IIPs) remains unclear.
  • This study compares MMP-7 expression in usual interstitial pneumonia (UIP) and cryptogenic organizing pneumonia (COP).

Purpose of the Study:

  • To investigate the role of MMP-7 in different types of IIPs.
  • To compare MMP-7 expression in UIP and COP.
  • To determine if MMP-7 differentiates between UIP and COP.

Main Methods:

  • Bronchoalveolar lavage (BAL) fluid and lung tissue samples were collected from normal controls, IPF patients, and COP patients.
  • Levels of MMP-7 and tissue inhibitors of metalloproteinase were measured in BAL fluid.
  • MMP-7 expression was assessed in lung tissues.

Main Results:

  • BAL fluid MMP-7 levels were elevated in both UIP and COP compared to controls, with no significant difference between UIP and COP.
  • Lung tissue MMP-7 expression patterns were similar in UIP and COP.
  • MMP-2 levels were higher in COP, and MMP-9 levels were higher in IPF.

Conclusions:

  • MMP-7 appears to be involved in the pathogenesis of both IPF and COP.
  • MMP-7 may not be a key factor for prognosis or reversibility in IIPs.
  • Further research is needed to elucidate the specific roles of different MMPs in IIPs.